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Cytokine Profile Of Chlamydia Pneumoniae Infected U-937
Macrophages
CA Gaydos, DG Pham, L Bono, TC Quinn.
1Johns Hopkins University, Baltimore, MD, 2NIH, NIAID,
Bethesda, MD
cytokines in C. pneumoniae infection.
Time Titer IL-I I IFN7 TNF-
IFU/ml Control Infected Control Infected Control Infected
24 hr 6.3 x 103 15.71 13.96 16.06 9.45 134.18 110.22
48 hr 1.7 x 103 8.88 8.88 4.68 5.05 72.56 79.41
72 hr 1.4 x 104 27.23 1.29 1.29 19.64 131.43 247.82
96 hr 3.6 x 103 48.34 BLDa BLD 48.08 365.56 447.71
7 d 0 46.23 BLD BLD BLD 202.51 421.59
a BLD= Below the level of detection. Control growth media was BLD for all 3 assays.
It has been demonstrated that C. pneumoniae can in-
fect U-937 human macrophages and it has been postulated Production Of 11-4 And IL-6 In HEp-2 Cells Infected With
that alveolar macrophages may play a role in the initial Chlarnydia pneurnoniae
pulmonary infectious process. Since it has been shown that PM Roblin,A Kutlin,MR Hammerschlag
C. trachomatis can induce mediators of inflammation and Department ofPediatrics, SUNYHealth Science Center
persistence and in order to begin to understand the patho- @ Brooklyn, NY
genesis of infections due to C. pneumoniae, we have inves- Introduction" An association of Chlamydia
tigated the cytokine response of U-937 cells infected in pneumoniae infection and reactive airway disease has been
vitro with C. pneumoniae, strain 2023. Non-adherent U- shown in children. Anti- C. pneumoniae IgE was demon-
937 macrophages (4 ml of 106/ml) were infected with ml strated by immunoblot in 85.7% of culture positive asth-
of 3.5 x 104IFU/ml of C. pneumoniae by gentle agitation matic children with wheezing compared with only 9.1%
every 20 min. for 6 hr, after which, 10 ml ofgrowth media culture positive children with pneumonia. Cytokines ini-
without cyclohexamide was added. Flasks were sampled tiate and perpetuate the chronic inflammaation of asthma.
by removing and freezing ml ofthe infected cells at 24 hr., IL-4 plays a critical role in switching ofB lymphocytes to
48 hr, and 7 days. A control flaskwas treated in an identical produce IgE, andmay therefore be of critical importance in
manner, except that uninfected growth media was used in the development of atopy. IL-6 can act synergistically with
place ofthe inoculum. After the 48, 72, and 96 hr. samples, IL-4. In this study we measured the production oflL-4 and
the flasks were split 1:2, in order to maintain persistence IL-6 from C. pneumoniae infected HEp-2 at various time
and viability. Titers of C. pneumoniae were determined for points.
each sample time point from the infected flask in Hep-2 Methods: Confluent monolayers ofHEp-2 cells were
cells. Cytokine levels were determined from the samples inoculated with seven C. pneumoniae isolates: J21, AR39,
from both the infected and non-infected flasks for the fol- BAL16, CDC8, JCW480, BAL15, TW1183, at 104 IFU/ml
lowing: IL-I, IFNy, andTNF-. The assayswere performed in cycloheximide free media. All results were calculated
by sandwich ELISA using reagents from EndogenTM. Both against moc-infected HEp-2 cell assayed in a sandwich
titers and cytokine levels were adjusted to reflect the dilu- ELISA for IL-4 (Intertest-IL4, Genzyme Corp., MA) and IL-
tion due to splitting ofthe cells in the flasks. The results of 6 (Biokine IL-6, T Cell Diagnostics, Inc., MA).
the viability titers and cytokine levels (pg/ml) are shown in Results: The results are shown below:
the table.
These results indicate that C. pneumoniae infection c. pneumoniae
in U-937 macrophages stimulate increased production of isolates IL-6 (pg/ml)
IL-11 by 96 hr. and IFN7as well as TNF-xby 72 hr. Mecha-
nisms of action ofthese cytokines may include, but are not J21 33.69
limited to, induction of adhesion molecule expression on AR39 28.53
endothelial and epithelial cells (IL-113); enhancement of BALI6 14.71
intracellular killing, TNF cytotoxicity, and NK cell activ- coc8 26.47
ity (IFNT); and enhanced macrophage killing and cyto- JCW480 8.82
BALI5 26.47
toxic T cell differentiation (TNF-o). Further study will en- TWI83 11.76
hance our understanding of the role of these and other
IL-4 (ng/ml)
24hr 48hr 72hr 24hr 48hr 72hr
39.57 58.55 0 0 0.016
41.63 45.15 0 0 0.26
32.35 38.24 0 0 0
II .76 8.83 0 0 0
26.47 38.24 0 0 0.082
5.88 47.21 0 0 0
17.65 41.18 0 0 0
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There was little or no detectable production of IL-4.
We also assayed forproduction oflL-4 and IL-6 in a HEp-2
cell line chronically infected with TW183. These cells
have been maintained for approximately year without
centrifugation, cycloheximide or addition of fresh cells.
Supematants were assayed from these infected cells for IL-
4 and IL-6 at a "lysis" stage where a majority ofcells appear
lysed and a "recovery" stage where remaining cells re-seed
and form a monolayer, at this stage cells are split into fresh
flasks. IL-4 production was 10 times greater than that seen
with "acutely" infected monolayers (0.135 ng/ml). IL-6
was 100 times higher at lysis stage, 2,044.0 pg/ml and 10
times greater at the recovery stage, 352.8 pg/ml.
Conclusions: C. pneumoniae stimulated the produc-
tion oflL-6 and minimally stimulated the production oflL-
4 in HEp-2 cells.
Chlamydia pneumoniae Induced Atheroscler0sis in Rabbits
K Laitinen, P Saikku.
National Public Health Institute, Oulu, Finland
Chlamydia pneumoniae (Cpn), an obligatory intrac-
ellular, Gram-negative bacterium, is a common cause ofres-
piratory tract infections worldwide. In addition to acute
infections it has been associated with chronic lung pro-
cesses. The most important finding is evidently the asso-
ciation of chronic Cpn infection with cardiovascular dis-
eases. The first serological association was published in
1988 in Finland, and after that several groups worldwide
have found the association between CHD and Cpn anti-
bodies. Direct evidence between Cpn and CHD is demon-
strated by finding Cpn organisms in atherosclerotic lesions.
It is also shown that Cpn can infect human endothelial cells
and macrophages in vitro, and according to recent evidence
these cells could carry Cpn into the smooth muscle cells
below the lining of the artery. Even if the association be-
tween Cpn infection and atherosclerosis has been confirmed
using several different methodological approaches by sev-
eral laboratories around the world, the causal relationship
between chronic Cpn infection and the development of ath-
erosclerosis can be indicated only by animal experiments
and intervention trials. Mouse has already proved to be
useful animal for the study of atherosclerosis, and the sus-
ceptibility ofartherosclerosis varies greatly between mouse
strains. With advances in molecular biology mouse strains
with genetic defects or overexpression of certain genes in-
volved in lipoprotein metabolism have been created and
are of great value for studies in atherogenesis. Mice are
also susceptible to Cpn infection and develop latent chlamy-
dial lung infection. Another animal model to study
artherosclerosis is theNew Zealand White (NZW) rabbit on
a high cholesterol diet, and hereditary hyperlipemic
Watanabe rabbit (WHHL). Moazed et al. has recently shown
that Cpn causes a moderate, self-limiting interstitial pneu-
monia in rabbits, and the infection mimics the human in-
fection. Purpose ofour study was to determine whether this
rabbit model is suitable for studying the development of
atherosclerosis after Cpn infection. Animals used were
Bordetella bronchiseptica and Pasteurella spp. free male
New Zealand White rabbits (5 mo old). Rabbits were in-
oculated intranasally with a total volume of 0.5 ml of or-
ganisms (2xl0 7 IFU/ml Cpn strain K7). Control animals
were inoculated with 0.5 ml sterile SPG medium. Rabbits
were reinfected in the same manner and with the same dose
3 weeks after primary inoculation. Rabbits were observed
daily for signs ofdisease andweighedtwice a week. Samples
were collected 2 weeks after primary infection and 1, 2 and
4 weeks after reinfection (5 and control/each timepoint).
Lung, spleen and liver tissues were homogenized. Isola-
tion was done in HL cell culture and inclusions were de-
tected with FITC-conjugated chlamydia genus-specific
antibodies. Lung. spleen, liver, heart and ascending aorta
were fixed in 10% buffered formalin immediately after re-
moval for histology and immunohistochemistry. No clini-
cal signs ofdisease were observed except in two animals 24
and 48 hrs after reinfection. One animal developed severe
lung oedema and the other animal had acute pneumonia.
All sample homogenates (lung, liver, spleen) remained cul-
ture negative during the course ofthe infection. Five weeks
after primary infection two out of four rabbits developed
early signs of fibrous plaques in aortas and seven weeks
afterprimary infection three rabbits (3/5) developed plaques
in ascending aortas. These animals were also found posi-
tive in immunohistochemistry. Control animals had no signs
of atherosclerotic changes.
seocP -A Serological’Assay ForThe Detection Of’
Chlamydia pneumoniae IgG, IgA and IgM Antibodies
A Groh,V Prankratova,M Lipson*,A Ben-Michael*, 0
Horovitz, and R MosckOvitz*.
Institute ofMedical Microbiology, Friedrich Schiller
University ofJena, Germany, *Department ofResearch
and Development, Savyon Diagnostics, Kiryat Minrav,
Ashdod, 77101 Israel
Objective: Chlamydiapneumoniae is a widely spread
pathogen responsible for infections ofthe upper and lower
respiratory tracts. Specific antibody prevalence of C.
pneumoniae is over 50% among adults worldwide, and is
low in pre-school children. Recently, there has been a grow-
ing number ofreports which suggest an association between
chronic C. pneumoniae infections and coronary artery dis-
ease. Additional studies stress the role of this pathogen in
Adult Onset Asthma. The SeroCP has been developed for
the determination of C. pneumoniae IgG, IgA, and IgM an-
tibodies.
Materials and Methods: SeroCP uses as antigen C.
pneumoniae strain TWAR 183 purified elementary bodies
(EBs). Serum samples were obtained from 13 adult patients
positive for C. peumoniae byPCR (PCRP), 28 patients posi-
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tive for C. pneumoniae by MIF-IgG >1"512(CWP), 35 chil-
dren negative for C. preumoniae and C. trachomatis by
MIF(CNPNT) and 49 healthy adults(HA). The C.
pneumoniaeMIF were interpreted as positive for IgG > "32,
for IgA >1:20 ad for IgM >1:20.
Results: The prevalence (%) of C. pneumoniae anti-
bodies in different patient groups as detected by MIF and
SeroCP, is summarized in the following table:
No. of




PCRP 13 85 92
CWP 28 100 100
CNPNT 35 3 0
HA 49 76 98
PCRP 13 92 54
CWP 28 100 96
CNPNT 35 6 0
HA 49 40 41
PCRP 13 0 0
CWP 28 21 0
CNPNT 35 0 0
HA 49 2 0
Conclusions: SeroCP is highly sensitive and specific
and well correlated with PCR and MIF. The MIF IgG titer
1"64 correlates with positive SeroCP IgG and MIF IgA titer
1:20 with SeroCP IgA. The ELISA based SeroCP is easy and
convenient to perform as compared to the technically de-
manding MIF test. In addition to IgG and IgA, SeroCP IgM
testing should be recommended for the adequate and sensi-
tive diagnosis, when IgG and IgA antibodies are produced
in low levels.
Protective Immunity Against Chlamydia psittaci Serotype
Strains
DS Carlos,S Jesus, B Francoise, S Armel, R Annie.
IPathologie Infectieuse et Immunologic, INRA, 37380
Nouzilly, France, 2Dept. Patologia Animal Facultad
Veterinaria, Campus de Espinardo, Murcia, Spain
The serotype stains of Chlamydia psittaci induce
several diseases among ruminants. One of them, enzootic
abortion ofewes, causes significant economic losses for farm-
ers and represents a danger for pregnant women. This dis-
ease results from the colonization ofthe placenta by Chlamy-
dia. Transmission ofthe infection, in a flock or to humans,
results mainly from the massive excretion of Chlamydia
which occurs at lambing or abortion, in infected placentas
and uterine fluids.
The immunity following abortion of ewes is strong
enough to prevent abortion and chlamydial shedding dur-
ing the next pregnancy. Killed vaccines, used in the past,
reduced the incidence of abortions but could not prevent
excretion. We developed a thermosensitive strain of C.
psittaci (1) which provided a live vaccine against abortive
chlamydiosis. This vaccine is able to avoid abortion and
chlamydial excretion at lambing. However, the use of a
recombinant protective antigen will be safer. This new vac-
cine should be as efficient as the live vaccine and should
allow the specific diagnosis of abortive strains in vaccinated
flock. In order to detect potential protective antigens, the
cellular and humoral immunity against C. psittaci abortive
strainswas studied in amouse model ofsystemic infection (2).
Donors mice were intravenously infected with live C.
psittaci. One month after inoculation splenic cells were
transferred to naive recipient mice, which were challenged
with 2.105 plaque forming units (pfu) ofa virulent strain one
day later. Protection was assessed after 6 days by measuring
the decrease in spleen infectivity. This model showed that
lyt-2
/ T cells play the major role in the protection (3)
The importance ofhumoral immunity was assessed in
a pregnant mouse model. Mice were passively immunized
intravenously at day 11 ofgestation with polyclonal sera or
monoclonal antibodies (mabs). Mice were challenged on
the following day, and protection was measured by placen-
tal and fetal colonization four days later. The number of
living offspring 8 days after birth was also used to assess the
protection. Results showed that immune sera and type spe-
cific mabs could transfer protection, probably by neutraliz-
ing chlamydiae during the bacteremia which proceeds pla-
cental colonization.
Therefore, mabs raised against the ovine abortive strain
AB7 were produced in order to detect molecules beating po-
tential protective epitopes. The protective effect ofthese mabs
was tested in vitro by neutralization assays. The mabs selected
in vitro were tested for their ability to protect pregnant mice
after passive immunization. All the protective mabs were di-
rected against heat sensitive epitopes located on an 110 kDa
(apparent molecular weight under non denaturing conditions)
oligomeroftheMajorOuterMembrane Protein(MOMP) ofC.
psittaci strainAB7 (4). The protective mabs did not react with
the 39 kDa monomeric MOMP which is produced after heat
denaturation.
Protection experiments were performed on a pregnant
mouse model with vaccines containing mainly native
oligometric MOMP. Different formulations were tested and
mice were immunized with two injections given at 15-days
interval. They were challenged intraperitioneally at day 11 of
pregnancy (1 month after the last vaccination) with 2.105 pfu
oftheAB7 ovine abortion strain. Protection was evaluated by
the number of living offspring per litter and by the level of
infection in the livers, fetus and placentas (5). The level of
infection in the placentas was the most discriminant test.
Mice vaccinated with non-denatured MOMP extracts
were better protected than mice which have received a heat
denatured MOMP extract. The infection of the placenta was
significantly higher for mice which have received the heat
denatured vaccine, whereas the difference seen in the number
of living offspring between the 2 groups, was less significa-
tive. Mice vaccinated with the heat denatured vaccine were
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not protected from placental infection but they were partially
protected from abortion. As previous works have shown that
mabs raised against monomeric denatured MOMP were not
protective, this partial protection could be the result of T
cell epitopes located on MOMP.
In definitive, the good level ofprotection which have
been obtained could be the result of the combination of
MOMP native B cell epitopes and MOMP T cell epitopes.
In this model, we demonstrated that placental colonization
ofpregnant mice could be prevented with native oligomeric
MOMP. Mice vaccinated with native oligomeric MOMP
were protected from abortion but also from infection. The
last point is very important since chlamydial excretion at
lambing is mainly responsible ofthe contamination ofother
animals.
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ScarringTrachoma Is Associated With Polymorphism In
The TNF-Alpha Gene PromoterAnd With Elevated Tnf-
Alpha In Tear Fluid
DJ Conway,MJ Holland, RL Bailey,AE Campbell, S
Mahdi, RJennings, EMbena, DCWMabey.
Department of Clinical Sciences, London School of
Hygiene & Tropical Medicine, Keppel Street, London
WCIE 7HT, UK
Polymorphisms in the promoter region of the tumor
necrosis factor (TNF) -alpha gene have recently been shown
to be associated with an increased risk ofsevere malaria and
of mucocutaneous leishmaniasis. In an attempt to deter-
mine the role of TNF-alpha in the fibrotic sequelae of hu-
man Chlamydia trachomatis infection, we have looked for
associations between TNF-alpha levels in ocular secretions,
and between polymorphisms in the TNF-alpha gene pro-
moter region, and scarring trachoma in a case-control study
comparing 153 age, sex and village matched controls in a
trachoma endemic Gambian population. A higher propor-
tion ofCases (28%) than controls (18%) had the -308A al-
lele, particularly as homozygotes (X’- for trend, p=.032). The
trend was similar, but non-significant for the rarer -238A
allele, and highly significant for the number ofeither-308A
or 1238A sites in an individual (p=0.003). These associa-
tions were independent ofHLA class I or class II types. TNF-
alpha was detected more frequently in tear samples from
cases (38%) than from controls (16%), the association in-
creasing for higher concemrations ofTNF-alpha (p=0.015).
Among cases, detectable TNF-alpha in tears was highly as-
sociated with the presence of ocular chlamydial infection
(p<0.001). These results suggest that TNF-alpha plays a
major role in the cicatricial sequelae of C. trachomatis in-
fection in humans.
Characterization OfThe Local Immune ResponseTo
Chlamydia TrachomaasAmongTrachoma PatientsWith
Conjunctival Scarring
2S Phan, 3R Pham, 2D Dean
1Dept. ofMedicine, Division ofInfectious Diseases, and the
2Francis I. Proctor Foundation, University ofCalifornia at
San Francisco School ofMedicine, San Francisco, Califor-
nia, and SSanta Clara Hospital San Jose, California
Chlamydia trachomatis is the etiologic agent of tra-
choma which has a worldwide distribution and is the leading
cause of preventable blindness in the world. Progression of
disease from repeated infection in childhood is common and
results in the sequelae of conjunctival scarring that indirectly
leads to blindness. The immunopathogenic mechanisms for
the development of scarring are not well defined. In order to
address this issue, we evaluatedVietnamese trachoma patients
with conjunctival scarring who were undergoing corrective
lid surgery fortrichiasis. ControlwereVietnamese individuals
with conjunctival scarring due to other causes. Patients were
examined and scored for trachoma based on the World Health
Organizationtrachoma grading scale. Serumwas obtained for
microimmunofluorscence testing (MIF). Conjunctival swabs
were collected forDFA and PCR. Conjunctival biopsies were
obtained at the time of surgery for RT-PCR to quantitate and
type cytokines and to detect C. trachomatis, and for immuno-
histochemical studies. All cases revealed a grading C3 (severe
scarring with distortion ofthe lid). Five (36%) of 14 cases had
documented chlamydial organismsbyDFA and/orPCR orRT-
PCR; none ofthe controlswere positive for chlamydia. Immu-
nohistochemical studies revealed a statistically significant
higher level of CD4 (p<0.04) and CD8 cells (p<0.01), and
macrophages (p<0.05) in cases than controls; there were no
difference forB cells. Five cases had elevated interferongamma
(IFN,) levels; these 5 correlated with both a lack of demon-
strable organismsbyDFA, PCR, orRT-PCR, and elevated IL-2
levels (p<0.034). IL-6, and IL-12 levels were elevated among
cases but not controls (p<0.04); only 5 cases had elevated
levels forTNFa. There were no differences for IL-4. The data
reveal that chlamydia are present in trachoma cases even with
burned out disease although viability could only be confirmed
in one patient. Elevated IFN3, levels may have contributed to
elimination of the organism and lack of identification of C.
trachomatis in five cases. The cytokine profiles in this study
were characteristic ofboth Th-1 and Th-2 responses, and sug-
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gest that these may be important in regulating host immune
defenses against persistent C. trachomatis infections orpersis-
tent chlamydial antigen. Further study is required ofthe cell
mediated immune response to chlamydia which will likely
impact the direction of vaccine development of tr
The Relationship Between The 60 Kd Heat Shock Protein
(HSP60),Antisperm Antibodies And Undetected
Chlamydia trachomatis Infection In Male Partners Of
CouplesWith Undiagnosed Infertility
MG Munoz, J Jeremlas, ss Witkin
Universidad Simon Bolivar, Caracas, Venezuela and
eCornell University Medical College, New York, New
Yorg, us
Introduction: Heat shock protein 60 kD (HSP60) is
producedbymammalian cells in response to several stresses,
i.e. infection, inflammation and elevated temperature. The
aim of this investigation was to demonstrate the relation-
ship between heat shock protein concentration in semen,
antisperm antibodies and Chlamydia trachomatis infection
in the male genital tract.
Materials and methods: We examined the presence
ofliSP60 in semen from 64 male partners ofinfertile couples
with no history of C. trachomatis infection and whether its
presence was related to sperm antibodies (detected by
immunobead binding) and anti-chlamydial antibodies
(SERO ELISA, Savyon). HSP60was detectedby an enzyme-
linked immunosorbent assay (ELISA) using a monoclonal
antibody to HSP60 bound to wells of a microtitre plate and
a polyclonal antibody to HSP60 as the detecting antibody
(Stress Gen). HSP60-specificmRNAwas detected inmono-
nuclear cells isolated from semen by a PCR ELISA.
Results: HSP60 was detected in semen from nine
(14.1%) men, while HSP60mRNAwas present in 16 (25.0%)
samples. Spermatozoa from 12 (18.8%) men had bound
auto-antibodies, while 20 (31.3%) semen samples had anti-
chlamydial antibodies. The presence of HSP60 in semen
was correlated with the occurrence of sperm antibodies (P=
0.008), anti-chlamydial immunoglobulin A antibodies (P=
0.002) and HSP60-specificmRNA in seminal mononuclear
cells (P= 0.03).
Conclusions: The results demonstrate that HSP60 is
produced in the male genital tract and is present in a soluble
form in semen in association with genital tract immune ac-
tivation and/or a genital exposure to C. trachomatis. Lym-
phocyte activation apparently represents one source of
HSP60. Non-lymphoid cells or microorganisms may also
contribute to the total HSP60 level in semen. The role of
HSP60 in activating or inhibiting immune responses within
the male genital tract will be the purpose of future studies.
Chlamydia trachomatis Specific ImmunoparametersAnd
Cytokine Production In Semen From Males Affected By
Prostatitis
FMeacci,A SaM and S Mazzoli
S. TD. Center, Infectious Disease Unit, Santa Marie
Annunziata Hospital Florence, Italy
Introduction: The etiopathogenetic role ofChlamy-
dia trachomatis (C.t.) has not yet been completely demon-
strated in relation to deep male genital tract acute and
chronic pathologies; the micro-organism has been detected
in prostatic secretions, prostatic biopsies, in Sertoli cells
from testicular biopsies and in semen. The biology of the
micro-organism, the intracellular parasitism and metabo-
lism, influences and determines the infection evolution to-
wards the chronicity and the following tissue inflammation
in affected patients. In males the C.t. infection has been
associated with fertility alterations due to tissue degrada-
tion processes, functional or immune related alterations of
the genital tract or ofthe spermatozoa and with pathologies
of the upper genital tract such as prostatitis and infertility.
Chlamydia trachomatis has been additionally reported to
act particularly stimulatory for the appearance ofthe secre-
tary (S)IgA in the genital tract. The intrinsic capacity ofthe
male genital tract to produce SIgA is well documented and
can take place both in the prostate and the epididymis,
resulting in local targeted overproduction of SIgA by sub-
mucosal plasma cells. The induction mechanisms, the regu-
lation ofthese immunoresponses and the TH immuno-shift
in the male genital tract are poorly understood up to now.
The overproduction of SIgA could be theoretically ex-
plained by release of cytokines such as interferon gamma,
interleukin-5 and tumor necrosis factor alpa. Cytokines are
important mediators in inflammatory processes and their
production may modulate immunity during C. t. infections,
as proved by recent in vitro studies. In our previous studies
we proved elevated IL-6 concentrations and overproduc-
tion in semen of chronic prostatitis patients.
Aim ofour study: We investigated on IL-6, IL-4, IL-
0 mucosal presence in relation to C. t. specific IgA, SIgA
and IgG content in seminal fluids of 110 men affected by
prostatitis. Additional objective was to determine the pos-
sible TH response and the possible correlation between
cytokine production and the presence of Chlamydia
trachomatis DNA in semen ofthe patients.
Study population" Patients’ study inclusion criteria
were the presence of acute or chronic prostatitis; the popu-
lation has been select in a study period of seven months
from November 1995 to June 1996. Patients’ symptoms
were urethrorrea, pollachiuria, stranguria, haemospermia,
perineal pains, tenesmus and infertility (8.2%); patients
ranged from 21 to 73 years-old (m age=39.5). C. t. was
searched in patients semenby a modifiedPCR (Roche D.S.,
Germany). Specific anti C. t. IgAwere detectedby IP (Savyon
D. Ltd., Israel), MIF (Labsystem, Finland) an anti C. t.MOMP
ELISA test (SeroCTby Savyon D. Ltd., Israel) and IgG were
detected by SeroCT, Savyon D. Ltd., Israel. IL-6, IL-4, IL-
l0 were detected by research quantitative ELISA tests
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(Biokine, T-Cell Diagn. Inc. and Predieta Genzyme, USA).
Results: Sperm C.t. DNA was present in 13/110 pa-
tients (11.8%). IgA by MIF and HP were present in 40/110
patients (36.36%). IgA anti MOMP detected by an ELISA
test were present in 16/110 patients (14.5%). Sperm C. t.
MOMP IgG was demonstratedby SeroCT ELISA in none of
the patients excluding the possible transmembrane translo-
cation from sera ofthese antibodies or the local production
demonstrating the long-term infections. Western-blot analy-
sis of semen and serum IgA and IgG immunoresponse
proved a specific immunization versus C. t. specific pro-
teins, both in C. t. DNA positive pts. and in C.t. IgA positive
pts. IL-6 was present at concentration >10 pg/ml in ejacu-
lates of 10/110 (9.1%) patients; IL-10 was present at con-
centration >10 pg/ml in 23/110 (20.9%). A good correla-
tionwas found between IL-6 and IL-10 production (r=0.623)
in these patients. IL-4 was not measured at detectable lev-
els in ejaculates of our patients. Thus may be due to its
rapid metabolism.
Conclusions: Our patients with anti C. t. IgA posi-
tive prostatitis have DNA proven "Chlamydial" prostatitis in
30.7%. They presented specific local immunization against
the micro-organism western-blot proved, local overproduc-
tion ofIgA confirming the proper immunoeompeteney ofthe
genital tract. C. t. DNA positivity confirmed the presence of
the micro-organism as a possible "primum movens" of the
pathology.
Concerning the IL-6 and IL-10 local production it is in
vivo well documented in our patients affected by prostatitis,
confirming the production ofthese multifunctional cytokines
in human chlamydial prostatic infection, too. 20.5% of the
semenIgA positive patients presented high level ofIL-10. The
presence ofIL-10 in ejaculates ofoutpatients seems related to
a TH2 shift of the immune response, probably strictly con-
nected with the infection persistence and with possible modi-
fications of the micro-organism (latency?) causing the infec-
tion; only one ofthe semen IgA-IL-10 positive patients dem-
onstrated the presence ofplasmidic C. t. DNA.
The biological role ofIL-6, the presence ofother Th2
related cytokines and the secretory IgA overproductionmay
be important factors in micro-organism clearance, in modu-
lating the passage from acute to chronic prostatic infection
and may be involved in the possible determinism of pros-
tate cancer. All these observations seem thus emphasized
from our findings confirming the pathogenesis ofprostatitis
as immuno related.
Detection Of C. trachomats DNA and Chlamydial
Inclusions Using Non Radioactive In Situ Hybridization
And Apaap Staining Of Placental Samples
M Gencay,M Puolakkainen,TWahlstrom, PAmmala,
L Mannonen,A Vaheri,M Koskinlemi
Haartman Institute, Department ofVirology, and Depart-
ment ofObstetrics and Gynecology, University ofHelsinki,
Finland
Objectives: Our aim was to study placental tissue of
a stillbirth fetus, born to a mother with high antibody titers
to Chlamydia trachomatis, using non radioactive
RNA:DNA hybridization and alkaline phosphatase-anti-
alkaline phosphatase staining (APAAP) for C. trachomatis.
Method: In situ hybridization
For the probe preparation for in situ hybridization, C.
trachomatis L2 plasmid DNA was subeloned into a
polylinker site ofapGEM-3Zf(-) vector [L2PpGEM]. RNA
transcripts were synthesized using linearized and purified
L2pPGEM as a template. To shorten the probe and to facili-
tate diffusion into the tissues, probes were hydrolized un-
der alkaline conditions. Nonspecific probe was prepared
from vector [12PpGEM] by the same method as specific
probe. Infected and uninfected McCoy cells were used to
check performance of the probes. C. trachomatis specific
and non-specific probes were used for the detection of the
C. trachomatis DNA in paraffin embedded tissue sections.
Alkaline phosphatase-Anti-Alkaline phosphatase
(APAAP) staining
APAAP staining of chlamydial inclusions in tissue
sections was done as previously described by Mahony (1)
with slight modifications and counterstained 10s in Mayer’s
hematoxylin. To control the nonspecific staining, dupli-
cate tissue sections were incubated withmouse ascites fluid.
Slides were examined by light microscope.
Results: C. trachomatis specific nucleic acid and
chlamydial inclusions were detected in placental specimens
by in situ hybridization andAPAAP staining. Using appro-
priate negative and positive controls, these tests indicated
the presence of C. trachomatis in the placenta whereas PCR
tests for HSV-1, HSV-1, Varicella-zoster virus and toxo-
plasma gondii were negative.
Conclusions: This is the first case that shows the
presence of C. trachomatis in human placenta. C.
trachomatis is the most common sexually transmitted dis-
ease and it is usually asymptomatic. C. trachomatis in pla-
centa exposes the fetus to the infection and may cause birth
complications. These findings stress the need for further
studies of C. trachomatis infections during pregnancy be-
cause specific therapy is available.
References
1. Mahony JB, Sellors J, Chrnsky MA. Detection of Chlamydial
inclusions in cell culture or biopsy tissue by alkaline phosphatase-
anti alkalin phosphatas staining. J Clin Microbiol 1987;25:1864-
1867.
Prevalence And Viability Of Chlamydia trachomatis In
nfertileWomen
HC Gerard, PJ Branigan, SS Minasslan,AP Hudson.
Allegheny University, Dept. ofMicrobiology and Immu-
nology and Division ofReproductive Endocrinology and
Infertility, Philadelphia, PA 9129
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Previous studies have suggested that the intracellular
bacterium C. trachomatis is associated with infertility in
women. We developed polymerase chain reaction assays
targeting the 16S RNA and the major outer membrane pro-
tein(MOMP) genes to examine endometrium, fallopian tubes
and cervix samples from infertile women. PCR assays use
primers targeting the 16SRNA andMOMP genes to amplify
chromosomalDNA directly or linked to a reverse transcriptase
to analyze 16SRNA primary transcripts and messengerRNA
for MOMP. We first used PCR assays to investigate the
presence of C. trachomatis in subclinical endometrial and
tubal chlamydia infection. Seven consecutive endometrial
biopsies and ten tubal fallopian samples were obtained for
PCR and RT-PCR analysis. Five of seven patients’ cervical
and endometrial samples were found positive for chlamy-
dial DNA by these PCR assays. Importantly, endometrial
samples from two PCR-negative patients (cervix) were PCR
positive for chlamydial DNA revealing the presence of C.
trachomatis in the upper genital tract. We and others re-
ported the presence ofDNA from C. trachomatis in fallo-
pian tubes from infertile women and we have determined
whether C. trachomatis is metabolically active during in-
fection. Ten fallopian tubes samples from female patients
with ectopic pregnancies were also tested forthe presence of
DNA from C. trachomatis and sevenwere found positive by
both PCR assays. RT-PCR analyses oftotalRNA from these
seven DNA fallopian tubes samples showed 16S RNA pri-
mary transcripts andmRNA fromMOMP in two ofthe seven
DNA directed PCR positive patients. Control RT-PCRs for
host cell actin transcript showed that each RNA preparation
was of adequate quality for analysis. These results demon-
strated that inapparent chlamydia in fallopian tubes are vi-
able and metabolically active.
Antibodies To Human 60 kDa Heat Shock Protein
(hsp60) In Sera OfWomen With Pelvic Inflammatory
Disease (PID) CorrelateWith Immune Response to a
Conserved B-Cell Epitope OfThe Chlamydia trachomatis
hsp60
K Bergstrom, SS Witkin, J Paavonen, P-A Mardh
andM Domeika
1Institute of Clinical Bacteriology, Uppsala University,
Uppsala, Sweden; 2Department ofObstetrics and
Gynecology, Cornell University Medical College, New
York, USA; 3Helsinki University, Helsinki, Finland
Objective: Antibodies to the C. trachomatis hsp60
have been shown in several studies to be associated with
PID. It has been hypothesisted that sensitization to the
chlamydial hsp60 leads to an immune response to the ho-
mologous human hsp60. Tubal occlusion in these patients
may be due to an autoimmune response to human hsp60
induced in tubal epithelia. In the present study we exam-
ined the association between humoral immunity to two syn-
thetic peptide B-epitopes of the C. trachomatis hsp60, one
of which is expressed in the human hsp60, and the pres-
ence ofabs to the human hsp60 inwomen with PID. Abs in
human sera to peptide 260-271, but not abs to peptide
151-162, were previously shown to react with homolo-
gous epitopes in human hsp601.
Materials and Methods: The study population con-
sisted of 129 women with PID. IgG and IgA abs to chlamy-
dial lipopolysaccharide (LPS) were detected as described
earlier2 in modification3. IgG abs to synthetic peptides
corresponding to amino acids 151-162 and amino acids
260-271 of the chlamydial hsp60, and to purified recom-
binant human hsp60 were detected by ELISA.
Results: IgG abs to human hsp60 were detected in
73 (56.6%) PID patients. The presence of abs to peptide
260-271 was correlated with abs to the human hsp60
(p=0.011). Antipeptide 260-271 abs were present in 36
(49.3%) women with, and in 15 (26.8%) women without
abs to human hsp60. As expected, abs to synthetic pep-
tide 260-271 were highly associated with presence oflgG
(p=0.0006) and IgA (p<0.0001) abs to the C. trachomatis
LPS (Table 1). In contrast, there was no association be-
tween abs to the chlamydial hsp60 peptide 151-162 which
is not expressed in the human hsp60 and immune response
to the human hsp60 (p 0.018).
Conclusions: Immune sensitization to the human
hsp60 was associated with a humoral immune response to
a conserved epitope of the chlamydial hsp60 in PID pa-
tients with serological evidence of exposure to C.
trachomatis upper genital tract infection in those women
who develop immune response to an epitope ofthe chlamy-
dial hsp60 cross-reactive to an epitope in the human hsp60.
Table I. Relation between IgG abs to a conserved C. trachomatJs
hsp60 epitope 260-271, IgG and IgM abs to the lipopolysaccharide
(LPS) of C. trachomatis, and abs to human hsp60 among 129 women
with pelvic inflammatory disease (PID)
No. with abs
Antibodies No. to peptide p value
assayed Outcome subjects 260-271 (X2test)
IgG anti-human hsp60 present 73 36 (49.3%) 0.011
absent 56 15 (26.8%)
IgG anti-C trachomatis present 98 47 (48%) 0.0006
LPS absent 31 4 (12.9%)
IgA anti-C trachomatis present 78 47 (60%) >0.0001
LPS absent 51 II (21.6%)
Referemces:
1. YI Y, Zhong G, Brunham RC, Continuous B-cell epitopes in
Chlamydia trachomatis heat shock protein 60. Infect. Immun
1993;61:1117-1120.
2. Brade L, Brunnemann H, Ernst M, et al. Occurrence of antibod-
ies against chlamydial lipopolysaccharide in human sera as mea-
sured by ELISA using an artificial glycoconjugate antigen. Fems
Immunol Med Microbiol 1994;8(1):27-41.
3. Bergstrom K, Brade L, Witkin SS, Mardh P-A, Brade H, Domeika
M. Characterisation of antibody response to chlamydia in pa-
tients with sexually acquired reactive arthritis. 1996;(In manu-
script).
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Humoral Immunological Response ToA Sequence OfThe
57kD Heat Shock Protein Common To Mouse And
Chlarnydia trachomats, in Mice Inoculated With a Chlamydia
trachornatis E Strain
MJ Borrego*,V Fuentes, E Bissac,MA Catry, F Eb, J
Orfila
*Laboratorio de Bacteriologia, Instituto Nacional de
Saude Dr Ricardo Jorge, Av Padre Cruz 1699 Lisboa
codex, Portugal
Chlarnydia (C). trachomatis is responsible forhuman
genital tract and eye infections in adults, and for respira-
tory tract infections in newborn children. Infection of the
female genital tract causes cervicitis and salpingitis. The
salpingitis due to C. trachomatis is considered responsible
for ectopic pregnancy and infertility. The pathogenic events
that lead to development of these pathologies are not
known; as repeated infection seems to play a role, immuno-
logically mediated mechanisms have been suggested. A
pathogenic role of delayed hypersensitivity of Chlamydia
57kD heat shock protein (HSP) has been proposed in estab-
lishing a chronic inflammation, leading to scarring associ-
ated with fallopian tube obstruction and subsequent infer-
tility. Various animal models have been used in order to
study this phenomenon. Tuffrey’s work (Br. J. Exp. Path.,
1986) indicated thatmouse constitute a good model to study
genital infection due to C trachomatis human strains. In
our study, we usedC3H/He and C57/B16 female mice. These
strains don’t belong to the same H-2 haplotype. Mice were
treated with progesterone (1.25mg per mouse) 7 days be-
fore intracervical (by vaginal route) inoculation with a C.
trachomatis genotype E stain isolated from a portuguese
patient (104IFU per mouse). Mice were reinoculated at days
39, 68, 94 131 and 164 after the first inoculation. At days 5,
18, 22, 29 and 36 after inoculation and month after each
reinoculation, a blood sample was taken from 5 mice of
each strain before sacrifice and research for C. trachomatis
in the different sections of the genital tract by culture and
PCR-AMPLICOR-COBASRcHETM Mice were also studied
for fertility at days 22, 36, 65, 92, 127, 162 and 191 of the
experimental procedure. Control animals were inoculated
and reinoculated with a L929 cell supernatant. Blood
samples, C. trachomatis research and fertility studies were
done as for inoculated mice. A peptide (E-10-A) chosen
from a common sequence of Chlamydia and mouse 57kD
HSP by epitope plates (25tl/ml) and reactivity of mouse
IgG antibody was analysed We also observed the sera reac-
tion to a recombinant 57kD HSP by Western-blot. The
microganism was detected by culture in the ovarian and
fallopian tubes at day 5 and the AMPLICOR-
COBASRAcHETM could detect the agent up to day 190 of
experiment. A serological reaction to the E-10-A peptide
and to the Chlamydia recombinant 57kD HSP could be
observed since day 5 in inoculated animals, and particu-
larly in the C3H/He mice. However no relation between
this humoral immunological response and fertility could
be established.
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The Presence Of Serum AntibodyToThe Chlamydial Heat
Shock Protein (CHSP60)
P Claman, L Honey, 2R Peeling,PJessamineB Toye
1Division ofReproductive Endocrinology, Dept. of
Obstetrics & Gynecology, Ottawa Civic Hospital
University ofOttawa, 2Laboratory Centrefor Disease
Control Winnipeg Manitoba, 3Division ofMicrobiology
and immunology, Department ofMedicine, Ottawa Civic
Hosspital, University ofOttawa, 4Division ofMicrobiol-
ogy, Department ofPathology and Laboratory Medicine,
Division ofInfectious Disease, Department ofMedicine,
Ottawa General Hospital University ofOttawa.
Objective: To study the utility oftesting for Chlamy-
dia heat shock protein 60 (CHSP60) antibodies in the diag-
nosis of tubal factor infertility (TFI).
Design: Prospective case control.
Setting: Canadian University Hospital Infertility
Clinic
Main outcome measures: Sera was collected from
77 women presenting for infertility investigation and ana-
lyzed for antibodies to both C. trachomatis and CHSP60.
Result: Antibodies to C. trachomatis by
microimmunofluorescence (MIF) were found in 10 of 16
(63%) women with TFI but also in 28 of 61 (46%) women
with other causes of infertility (p=0.2, OR=1.96,
95%CI=0.56-7.1). Seven of 16 (44%) women with TFI and
only 5 of 61 (8%) women with other causes of infertility
had anti CHSP60 antibodies (p=0.002, OR=8.7, 95%
CI=1.9-41.9). MIF testing has a 63% sensitivity and a 54%
specificity for detecting the presence ofTFI. A patient with
TFI is only 1.36 times more likely to have a positive MIF
test than a patient without TFI (positive Likelihood Ratio).
In contrast, the CHSP60 antibody test has a44% sensitivity
and a 92% specificity for the presence of TFI. A patient
with TFI is 5.5 times more likely than a patient without TFI
to have antibodies to CHSP60 (positive Likelihood Ratio).
MIF and CHSP60 testing in combination has a positive
likelihood ratio of 10 for the detection of C. trachomatis
associated TFI.
Conclusions: Antibody testing by MIF for C.
trachomatis alone is a poor test for predicting the diagnosis
of TFI. CHSP60 antibody testing is a more accurate test
than MIF in predicting Chlamydia associated TFI. These
tests should be used in combination as part of an initial
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infertility evaulation to provide a rapid means of diagnosis
and to save on unnecessary and costly interventive proce-
dures.
Functional Damage of the Fallopian Tubes and Immune
ResponsesTo Chlamydia trachomatis
Sziller*, SS Witkin**,M Ziegert**, P Fedorcsak*,Z
Papp*.
*Department ofObstetrics and Gynecology, Semmelweis
University Medical School Budapest, Hungary and
**Division ofImmunology and Infectious Diseases,
Department ofObstetrics and Gynecology, Cornell
University Medical College, New York, USA
Objectives’To determine serologic responses of pa-
tients with impaired transport functions of the Fallopian
tubes to two Chlamydial antigens L-2 and 60 kDa heat
shock protein in a Hungarian University setting.
Design: In a case-control study, serologic responses
to chlamydial antigens were examined in five groups of
patients. Group.. consisted of28 patients with ectopic preg-
nancy and histologically proven chronic salpingitis, while
Group II included 40 patients treated for ectopic pregnancy
without histologic signs of prior tubal infection. In Group
III, 41 patients seeking care for in-vitro fertilization were
enrolled with laparoscopically proven tubal factor infertil-
ity. Two groups of patients served as controls: Group IV
consisted of 12 infertile patients in whom impaired tubal
transport function was due to pelvic endometriosis as evi-
denced by laparoscopy, and Group V included 45 patients
with an uncomplicated mid-trimester pregnancy. In sera of
patients seropositive for Chlamydia trachomatis, serologic
responses to the 60 kDa chlamydial heat shock protein were
also determined.
Results: The prevalence of anti-chlamydial IgG
among patients with salpingitis-associated ectopic preg-
nancy, in women with ectopic pregnancy without histo-
logic evidence ofchronic salpingitis, and among those with
infection-related tubal infertility was 68% (19/28), 38%
(15/40), and 44% (18/41), respectively. In the control
groups 3 (25%) of 12 patients with pelvic endometriosis
leading to impaired tubal patency and 17 (27%) of64 preg-
nant had anti-chlamydial IgG detected. Sera of patients
seropositive for Chlamydia trachomatis were also evalu-
ated for the presence of antibodies to the 60kDa chlamy-
dial heat shock protein. The prevalence of ajti-HSP anti-
bodies was 63% (12/19) in Group I, 40% to the 60kDa
chlamydial heat shock protein. The prevalence of anti-
HSP antibodies (6/15) in Group II, 39% (7/18) in Group III,
0% (0/3) in Group IV, and 6% (1/17) in Group V, respec-
tively.
Conclusions: Besides a significantly higher preva-
lence of anti-chlamydial antibodies to a genus chlamydial
antigen, patients with tubal damage leading to ectopic ges-
tation or tubal infertility were more likely to have antibod-
ies to the 60 kDa chlamydial heat shock protein than those
with an uncomplicated pregnancy orwomen with impaired
tubal transport due to pelvic endometriosis. Our data sug-
gest that prior chlamydial infection is associated with an
increased risk of tubal infertility and ectopic pregnancy
also in Hungary. In addition, the presence of antibodies to
the chlamydial heat shock protein is a marker of infection-
related tubal damage.
Production Of ILl-13 In Response to Chlamydial Infection
in an In Vitro Model ofThe Human Fallopian Tube
KA Ault, 0 Tawflk,MM Smith King andJ Gunter
University ofIowa Hospitals and Clinics, Iowa City, L4
and University ofKansas Medical Center Kansas City,
KS.
Objectives: Cytokines are known to be important in
both the inflammatory response and antigen expression in
chlamydial infections. Interleukin beta (ILI-[) is an es-
pecially important cytokine because of its multiple pro-
inflammatory and fibrogenic properties. It is our hypoth-
esis that ILI- will be produced in response to chlamydial
infection in an in vitro model of the human fallopian tube.
Methods: Tubal segments are harvested at the time
of abdominal hysterectomy and processed using standard
tissue culture techniques. Three 4mm biopsies were taken
from the lumen of the fallopian tube. Two of these were
inoculated with 50 microliters of a x 108 solution of
Chlamydia trachomatis serotype E/UW-5CX elementary
bodies and one was "sham" inoculated. After forty-eight
hours, supernatant was assayed for IL1-1 using an enzyme
linked immunoabsorbent assay (Cytoscreen Immunoassay
Kit, Biosource International Camarillo CA). Additionally,
tubal segments were stained for ILI- using immunohis-
tochemical techniques with a polyclonal rabbit anti-hu-
man IL1-B. (Genzyme, Cambridge MA).
Results: Seven tubal segments were cultured. Mean
IL1-B levels for infected segments were significantly higher
at 69.54 pg/ml +/- 41.0 (mean +/- standard deviation) ver-
sus control values of2.4 pg/ml +/- 0.46 (p<0.005 with paired
t test). IL 1-13 was predominantly localized in the tubal epi-
thelium. Other areas with IL 1-13 included stromal cells mor-
phologically consistent with macrophages and fibroblasts.
Conclusions: The human fallopian tube produces
IL1-[ in response to infection with Chlamydia trachomatis.
Because of its biological properties, IL 1-[3 may play a sig-
nificant role in the early inflammatory response of the hu-
man fallopian tube as well as the eventual pathogenesis of
tubal damage.
Interest of Detection OfAntibodies In Ct PositiveAnd Ct
Negative Patients With Genital Infection
J Orfila, C Chaigneau,JM Sueur
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Biobanque de Picardie Amiens, France
Patients: 59 women and 19 men consulting for STD
detection. The clinical symptom varying from acute lower
genital infection to acute and chronic higher genital infec-
tion.
Protocol" All patients were submitted to urethral or
cervical collections in the following order:
first swab for cell culture on McCoy cells
second swab for LCR (Abbott lab)
third swab for direct immunofluoreseence (DFA) with
monoelonal antibodies (Syva)
fourth swab for detection of secretory IgA (Medac)
Blood sample were taken the same day in order to
detect IgG, IgM, IgA. Three differenttechniques have been
used: microimmunofluoreseenee with three antigens (C.
traehomatis, C. psittaei, C. pneumoniae ELISA (Medac)
using a recombinant LPS, ELISA (Orgenix) with two anti-
gens (C. trachomatis, C. pneumoniae) treated in order to
eliminate the LPS.
Results: C. traehomatis has been found in 22 patients
(group 1), 56 were negative by all technics (group II). Secre-
tory IgA were found for 11 patients from group I (50%) and
6 from group II (10.7%) with a significant difference be-
tween the two groups p=0.00005.




Medac 86.36 (I 9/22) 82.14 (46/56)
M.I.E 81.81 (18/22) 73.21 (41156)
PBS 72.72 (16/22) 51.78 (29/56)
IgM Medac 13.63 (3/22) 26.78 (I 5/56)
M.I.E 27.70 (6/22) 10.71 (6/56)
IgA Hedac 40.90 (9/22) 48.10 (27/56)
M.I.E 18.18 (4/22) 16.07 (9/56)
IgA Secretory 50 (I 1/22) 10.71 (6/56)
The analysis of the different results shows that MIF
and Medac ELISA have similar sensitivity with two pa-
tients with ELISA+ andMIF at the first visit. The two tests
becoming positive at the second visit. On the other hand
with Orgenix 2 patients positive with MIF and ELISA are
negative at the first visit. They became + with the three
tests later. It seems that anti LPS antibodies are the first to
appear or at least the first to be detected. However, the
small number of patients ask for a deeper investigation.
Considering the IgA humoral response we may describe
two types of response: 1) In ease of acute infection: 3 IgA
sero conversions were noted a fortnight after contamina-
tion and afterIgG sero conversion. After treatment IgA sero
negotiation has been noticed. 2) In ease of chronic infec-
tion: the presence of IgA was always linked to persistent
upper chronic infection. Secretory IgA: In spite of techni-
cal difficulties (the use ofthe fourth sample) the results are
rather satisfactory. S IgA was present in 50% of positive
direct im examination. With treatment secretory IgA be-
come negative in a few weeks.
Clinical Research Of Chlamydia Trachomatis Infection In
Women’s Genitals
XS Wen, yJ Lin, G Zhu
Dept. ofOb/Gyn, The First Affiliated Hospital, Harbin
Medical University, P.R. China
From July 1993 to July 1995, we detectedCT in 1487
gynecological outpatients by PCR (Polymerse Chain Re-
action). We also detected the response to therapy and the
host’s immunological response among the 218 patientswho
were positive for CT. The total positive rate was 26.09%
(388/1487). The risk age was from 21 to 35. We divided
218 patients into 3 groups and used 3 different treatments,
which were antibiotics, Chinese drugs and antibiotic com-
bined with Chinese drugs. The cure rate was 75% (45/60),
65.86 (48/75) and 92.86% (78/84) respectively. We com-
pared antibiotic therapy with Chinese Western drugs therapy
by x2test, x2=8.69, p < 0.01, the comparison between Chi-
nese drugs and Chinese Western drugs showed x2 =19.08,
p<0.01. The resultsdemonstrated the difference among these
three methods was obvious, the best was Chinese Western
drugs therapy. We also compared the difference between
before therapy level ofIgA, IgG and after- therapy level of
IgA, IgG by t test, tA=5.228, tG=3.175, p<0.05, the differ-
ence was also obvious. This result response which was not
specific according to the variety ofantibody, so the level of
antibodywas only regarded as a reference therapeutic evalu-
ation parameter.
Atypical Morphology of Chlamydia trachomatis in Patients
With Latent Infection
EE Bragina, MA Gomberg, OE Orlova
Moscow, Russia
The aim of this study was to evaluate in vivo
morphologic changes of Chlamydia trachomatis in order
to explain the ineffectiveness ofantibiotic treatment in some
patients with chronic chlamydia infection. At study entry
chlamydial infection was diagnosed by direct immunof-
luorescence (IF) and by cell culture (line L929) with IF
confirmation. Small atypical cytoplasmic inclusions (SACI)
containing chlamydial antigen were isolated in some cases.
The cultured cells usually contained several SACI around
the cell nucleus, and they did not enlarge during cultiva-
tion. They correlated with inclusions described earlier for
an in vitro model ofpersistent chlamydial infection. In our
study SACI were isolated from 16 patients (9 men and 7
women) 7-10 days after unsuccessful treatment with rou-
tine methods. Chlamydia in SACI continued to be isolated
6 weeks after treatment in 10 out of 16 patients and disap-
peared spontaneously in 2. One month later inclusions
disappeared in another 3 patients, but appeared again in
one. We performed an ultrastmcture study ofmaterial from
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these patients. Different stages of chlamydial life cycle
were revealed: adhesion ofelementary bodies (EB), intrac-
ellular inclusions, the export ofintracellular C. trachomatis
out of the host-cells. Only 2 small cytoplasmic inclusions
were found and both contained exclusively reticulate bod-
ies (RB) without any matured Ebs. Some ofthe RBs were at
the stage of division and in some others condensation cen-
ters were observed. We considered these inclusions as SACI
revealed in culture cells after isolation from patients in
whom infection persisted after unsuccessful antibiotic
therapy. In latency that clinically could not be distin-
guished from persistency, chlamydia do not demonstrate
any metabolic processes. The cases of chlamydial latency
are illustrated with extracellular mono- and polymembrane
vacuoles with chlamydial Ebs inside, or one EB, surrounded
with additional membrane layers. In some cases we have
demonstrated that these additional outer membranes are
originating from the host-cell membranes. These mem-
branes may prevent adhesion of EBs to the host-cell and
determine one ofthe ways ofdevelopment oflatency in the
early stages of the developmental cycle. Recently, some
data appeared concerning extracellular division ofchlamy-
dial RBs in vitro. We have found host-free dividing Rbs in
vivo that were morphologically different from the typical
intracellular ones. The outer membranes of the RBs with
several atypical condensation centres are separated from
the inner membranes and the protoplasm is dividing inside
enhanced periplasma spaces. Findings of morphological
changes of chlamydial bodies and their interactions with
the host-cells may explain the cases of persistence after
antibiotic treatment.
Immunologic Changes In Patients With Persistent
Chlamydial Infection
MA Gomberg,AM Solovyov
Department ofDermatology and Venerology Semashko
Moscow Medical and Dental School Moscow, Russia
It was shown earlier in vitro that some factors of im-
mune system may induce a persistence of Chlamydia
trachomatis. We estimated different immunologic data in
54 patients with chronic persistent urogenital chlamydial
infection. Persistence was confirmed by the atypical small
forms of chlamydial inclusions consisting ofnon-develop-
ing reticulate bodies in a cell-culture test (line L-929). Ac-
cording to the results ofthe study of antigenic landscape of
the lymphocytes and the level of immunoglobulins in the
peripheral blood all patients were divided into 2 groups.
Group consisted of 39 patients with decreased index in
their immune status. Group 2 was formed with 15 patients
inwhom the results ofthe immunologic study were normal
or even higher. In Group immunostimulative therapy was
used in 26 patients and the remaining 13 did not receive
the kind of treatment as well as all the 15 patients from
Group 2. Nobody with abnormal forms of inclusions re-
ceived antibiotic treatment. In comparison with healthy
volunteers there were found various changes in T-cell im-
munity and significantly decreased levels ofCD72+, CD21+,
CD16+ and HLA DR+ in patients with persistent chlamy-
dial infection. Most patient of Group 2 showed signifi-
cantly increased levels of CD3+, CD4+, IR1, CD72+ and
IgM. Culture tests were repeated 1-2 months after persis-
tent forms of C. trachomatis had first been revealed. Seven
out of 13 patients from Group who had not received
immunostimulative treatment had no C. trachomatis in the
second test, and in 6 C. trachomatis still persisted. Eigh-
teen out of 26 cases from the Group 1, who had received
immunotherapy, C. trachomatis disappeared, in 3 cases they
transformed into common forms, and in the remaining 5
Chlamydia still persisted. Twelve out of 15 cases from the
Group 2 C. trachomatis eliminated, patient showed a trans-
formation of chlamydia into common forms and in 2 cases
they persisted. So, C. trachomatis disappeared in77% ofcases
from Group after immunotherapy, in 54% ofcases from that
group when therapy had not been applied and in 87% ofcases
when from Group 2 were immunostimulative therapy was not
necessary. The disturbances in immune system may cause
non-complete climination of the persistent microorganisms.
Disappearance ofpersistent forms may be spontaneous.
The Immune Response In Chronic Chlamydious And
Chlamydious-Herpetic Infection of the Uro-Genital
System
V Danilejchenko,N Vynograd,V Chopjak
Department ofMicrobiology, Lviv Medical Institute,
Ukraine
The indices of cell and humoral immunity as well as
interferon status of 44 patients with chronic uro-genital
chlamydiasis and 35 patients affected with chlamydious
herpetic infection were studied. The analysis of data in
both groups of patients shows the presence of secondary
cell-stipulated state ofimmune deficiency which was more
marked in case ofmixed infection. The course ofthe illness
was followed by a decrease of T-cells, an increase in the
activity ofT-h and T-s subpopulations oflymphocytes. The
increase of relative and absolute count of O-lymphocytes
was observed. The changes in humoral link of immunity
were characterized by increases in the level of circulating
immune complexes and IgG. The active expenditure of
complement has been observed on both groups. This can
be proved by the fall of complementary activity of blood
serum. The study of interferon status of both groups, pa-
tients showed more considerable depression of interferon
producing activity of leukocytes in patients with mixed
chlamydious-herpetic infection. All these patients had
much lower ability to produce IFNc and IFN,. The distur-
bances in the immune and interferon systems in patients
with chlamydiasis and herpetic chlamydious infections mark
their significance in the pathogenesis of these infections
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the necessity offurther researches ofnew effective methods
oftreatment.
Peculiarities OfThe State OfThe Immune System In Girls
With Inflammatory Diseases Of Genitals Of Chlamydial
Etiology
LA Matitsina
Donetsk Regional Centre ofMaternity and Childhood
Protection, Donetsk, Ukraine
Urogenital chlamydiosis is at present a serious pa-
thology not only in women but also in girls. The pathogen
of the given disease Chlamydia trachomatis has tropism
to cylindrical epithelium coveting not only cervical chan-
nel and urethra tubes. We studied a group of girls of 86
persons aged from 7 to 18 with determined diagnosis uro-
genital chlamydiosis. This group consisted of girls who
were not treated at the moment of study. All girls with
chlamydiosis were diagnosed as monoinfection after tak-
ing a tage of urethra with subsequent macroscanning by
method of indirect fluorescence (with use of test-system
"Chlamiscanu") and coloring of the material according to
Romanoviski-Gemze. 69 (80%) patients were troubled by
genital discharge during 3-5 months. Discharge ofwhite or
yellow color was not profuse. 52 (60%) patients were
troubled by periodic pains at low art ofabdomen during 2-
5 months. Rectal examination of adnexia was determined,
painfulness, increase oftheir sizes. Ultrasonic examination
availability of inflammatory process of, internal genitals
(adnexitis, hydrosalpinz one or bilateral) in 73 (65.8%) girls
found that was displayed by the increase of ovary, the de-
crease of echogenity, the expansion of uterine tubes due to
liguid component. Hydrosalpinx is found out in 22 (30.9%)
patients, adnexitis in 24 (32.9%) salpingooforitis in 6 (7%)
patients, cystis 4 (5.5%), endometritis 5 (6.9%). Thus,
urogenital chlamydiosis is a reason for frequent complica-
tions on the part of internal genitals firstly uterine tubes,
taking into account the trobity of pathogen to their cylin-
dric epithelium,. Prolonged inflammation in uterine tubes
can result in narrowing of their lumen, total obliteration
and occurrence herein after tubal sterility. In present time
inflammatory process ofinternal genitals ofchlamydial eth-
nology take a special place. According to the modem view
chronic process in internal organs direct pathological in-
fluence for all system of organism and lead to disorder of
immunological parameters. This immunological disorders
ofcharacter ofdisease, time of its course and also influence
on the diagnostics and treatment. We studied immunologi-
cal status in 26 patients (girls of 7-13 years) with chronical
disease of internal genitales (chronical adnexitis, chronical
salpyngitis) and chronical vulvovaginitis. Immunological
status in these patients was escalated before the beginning
oftreatment. It was determined that on this stage the level
of T-lymphocytes averages 68.6 + 3.4% (range 69-85%)
level B-lymphocytes 12.6 + 0.9% (in normal 110-17%),
phagocytic activity of neutrophils nitrofils (NST- test for
B.H. Park, 1968) average 1.4 + 0.1% (in normal 11.20
1.52; 48.0 54.0%), the level IgA consist in average 1.86 +
0.2g/1 (in normal 11.0-2.6g/1); IgG averages 12.07 + 1.96
(in normal 8.0 + 14.3); level IgM 2.18 + 0.71, in normal
0.8 -1.4); the level IgE averages 258.6 + 5.6 ng/ml (30 350
mmg/ml), CIC averages 81.6 + 2.9 (in normal 40-70) In all
patient we investigate the level of secretary IgA in vaginal
secrete and this level averages 0.27 + 0.03 (was increased).
In all patients the level oflymphocytes in peripheral blood
was increased too and consisted 44.2 + 4.6. The content of
IgM in patients with urogenital infections was increased.
In patients with chronic imflammatory diseases of genitals,
produced by CT, the absence ofchanges in the condition of
the cellular link of immunity may be connected with low
immunogenity ofCT and peculiarities of the vital cycle of
the agent. It should be noted the increase oflgM in numer-
ous cases, that confirm the activation ofB-lymphocytes by
chlamydia. Our findings are coodinated with the results,
received by other authors earlier who established that CT
in the system in vitro indicated proliferation of B-lympho-
cytes ofperipheral blood and in the presence ofT-lympho-
cytes differentiation of B-lymphocytes into cells secreting
immunoglobulins. Thus, in girls with inflammatory dis-
ease in internal genitals the increase of the IgM levels in
serum and levels ofcirculating immune complex (CIC) and
others immunological parameters are marked. The received
data have allowed us to conclude about the efficiency of
application of immunological methods of investigation to
inflammatory disease of internal genitals.
Diagnostics And Treatment Of Chlamydia Infection In
WomenWith Preterm Labor
TN Dyomina, IB Yakovleva
Donetsk State Medical University, Donetsk, Ukraine
From 0.5 to 39% of women with genital inflamma-
tion also have chlamydia infection, but one’s role in the
habitual preterm labor (HPL) is not well known. The aim of
this paperwas to determine the share ofwomen with chlamy-
dia during HPL. The informativity of the hybridization
revealing chlamydial DNA and RCC methods and connec-
tion between endometrial and placenta contamination were
also studied. We examined 87 patients withHPL (from 2 to
10 abortions) ages 18 to 36. Chronic genital inflammation
was revealed in 74 women. Chorion and placenta were ana-
lyzed after abortus in 8-24 weeks in 12 patients. The fur-
ther examination ofsamples were made after 2-4 months in
the first phase of the menstrual cycle. Samples were taken
from the cervical canal and urethra by Folkman’s spoon.
RCC is based upon calculation of the amount of comple-
ment which is consumed by the antigen-antibody complex.
The antigen is the ornithosic antigen. In the method ofthe
hybridization revealing chlamydia DNA, the technique of
pointal hybridization of nucleic acids on solid phase with
206 INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGYINTERNATIONAL SYMPOSIUM: IMMUNOPATHOGENESIS OF CHLAMYDIA INFECTIONS ABSTRACTS
DNA-Zonde marked with biotin was used.
The analysis includes several steps:
1. Preparation of the nitrocellulose filter, which is used
as a solid phase, to hybridization. The filterwas moist-
ened in distilled water, then in NaC1 and HNO3 solu-
tions, then one was dried in the air.
2. The preparation of the samples. The suspension of
cells of the analyzing material was mixed with the
lysing solution, thenmn 2 hours at 55 C. After cen-
trifugation, the over-fallout liquid was taken into a
clean test tube, then ethyl alcohol was added. It ran
one night at minus 20 C. After this, the sample was
centrifuged. Over-fallout liquid was poured off, the
solid fallout was dried in air and dissolved in a small
amount of the salt solution. The samples and the
control samples were denatured in boiling water bath,
then the test tubes were quickly removed into the ice
water bath and deposited onto the filter. The filter
was dried in the air andbaked in 80 C during 2 hours.
3. Hybridization. The filter with samples was soaked in
distilled water, put into the petri dish and covered
with prehybridization solution. The filter was incu-
bated during 2 hours. Then the prehybridization so-
lution was poured out, and the hybridization solu-
tion was added. Hybridization ran during night.
Then the filter was cleaned out from the unreacted
zonde. The filter was plunged into blocking solution
to prevent nonspecific conjugate binding, then it was
put into conjugate solution. After this, the filter was
cleaned one more time with a special solution, then it
was covered with revealing solution and mn until
there was colour in the spot with the positive control.
The filter was cleaned with distilled water and dried.
4. Results. The hybridization results were evaluated vi-
sually by comparison with the colour of the control
samples. In proper reaction technique, the positive
control spot is blue. The negative control spot is
colourless. Otherwise the test mustbe made fresh. The
intensive coloured samples are treated as positive
samples.
To diagnose chlamydia infected abortuses, x 1 x
cm pieces ofplacenta or chorial tissue were taken. Then the
tissue was dissected through all layers and from the dissec-
tion surface the tissue samples were taken to analyze
chlamydia by revealing DNA of the exciter.
During analysis ofthe cervical canal and urethra, we
found that 27 (37%) ofwomen were infected in RCC reac-
tion and 38 (43.7%) in the DNA hybridization reaction.
During localization, 14 patients had injury of the cervical
canal or urethra, and 18 had injury of the cervical canal
only. The women with chronic relapsing inflammation of
uterine appendages had chlamydia infection more often
than other women in the analyzing group. Chlamydia was
bound with chorion and placenta in 4 samples from 12.
The DNA revealing method is more effective than RCC.
The DNA revealing method reveals chlamydia in 95.4 %.
All women with chlamydia and their sexual partners were
thoroughly treated. Patients received drugs which had in-
fluence over immune reactivity (tactivin and timolin),
biostimulators (aloe, plasmol, hyaloid body), pirogenal or
prodigiosan, vitamins R, C, methyluracil. If the tempera-
ture reaction had occurred, patients received the tetracy-
cline series antibiotics, eritromycin, cyprobai, sumamed
with trichopol (after 8 days of therapy). Patients also re-
ceived antomycotic drugs nistatin, levorin, clotrimasol.
From the 3rd day, the vagina had been sanatedby anticeptical
solutions (protargol, furacillin) and complex gels with
tetracyclin and dimexid. During the 3rd week, patients
received physiotherapeutic methods (ultrasound to the bot-
tom of stomach, dyodinamic current, low-intensive laser
beams to vagina and the uterus neck, variable zone decom-
pression). After therapy, chlamydia was revealed in 4
women, which received the therapy one more time. 18
women after therapy were pregnant and had normal labour
and healthy babies. So, 32.4% ofwomen with chronic re-
lapsing inflammation of uterine appendages also had
chlamydia infection.
Chlamydia trachomatis Cervical Infections: Some
Characteristics
IM Linhares, SD Miranda,AM Fonseca, EG Percyra,VR
Bagnoli, RGAImeida,H Melles, LFG Siqueira
STD/AIDS Service, Gynecol/Obstet. Dept., Sao Paulo
University Medical School Brazil
Objective: The aim ofthis study was to contribute to
the knowledge of the prevalence, epidemiological charac-
teristics and clinical characteristics of Chlamydia
trachomatis cervical infections.
Methodology: We studied 166 women complaining
of abnormal vaginal discharge (group A) and 25 women
without complaint of vaginal discharge (group B). All pa-
tients were submitted to culture for Chlamydia trachomatis
in cervical secretion. For the women whose cultures were
positive we analyzed age, race, complaint of pelvic pain,
pain at sexual intercourse, sexual antecedents, gynecologi-
cal examinations characteristics, vaginalpH and Gram stain.
Results: The Chlamydia trachomatis culture was posi-
tive in 15(9.0%) patients of group A and in 3(12.0%) of
group B. For these positive cases, the age varied from 14 to
51 years (x=33.7) being 12 patients white and 3 black in
the group A. In group B the age varied from 22 to 41 years
(x=28.6) and all the patients were white. Pelvic pain and
pain at sexual intercourse were referred respectively for
8(53.4%) and 7(46.7%) patients ofgroupA and for 1(33.3%)
and 1(33.3%) patient of group B. The sexual antecedents,
gynecological examination characteristics, vaginal pH and
Gram stain ofthe both groups are representing in the tables
1, 2, 3 and 4, respectively.
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Table Sexual Antecedents
Group A Group B
First intercourse 12-29 years(x= 18.3) 16-33 years(x=22.3)
Sexual habits 100% heterosexual 100% heterosexual
One sexual partner 10(66.6%) 3(I 00%)
Two sexual partners 3(20.0%) 3(66.6%)
Three sexual partner 2(I 3.4%)
Table 2 Gynecological examination characteristics
Painful cervical mobilization
Presence of vaginal discharge
Painful anexial examination
Presence of cervical discharge













Table 4 -Vaginal Gram stain
Group A Group B
AR S N A R S N
leucocytes 6 6 2 2
Dodericin bacilli 6 2 7 2
Gram positive cocci 9 6 3
Gram negative bacilli 5 8 2 2
A= Absence; R= Rare; S Some; N Numerous.
Conclusions:
1. The prevalence ofChlamydia trachomatis was similar
in symptomatic and asymptomatic women.
2. The cervical infection was observed in young women
and women over 40 years old.
3. The absence of clinical complaints do not exclude the
possibility of Chlamydia trachomatis presence.
4. The same considerations are valid for women who
have only one sexual partner.
5. The gynecological examination for the patients with
cervical Chlamydia trachomatis may present differ-
ent characteristics or not show alterations.
6. The Gram stain does not offer any indication of the
infection.
7. Considering the serious consequences of the compli-
cations for women’s health of a silent infection, the
authors suggest the necessity ofperiodical screening.
The Investigation Of Chlamydial Infection In Tubal
Infertility
JA Tait, J Hewitt,WTong
Liverpool Women’s Hospital, Liverpool, United Kingdom
Objective: To find, using PCR gene amplification
technique, what proportion of infertile women with tubal
obstruction, (excluding endometriosis), have evidence of
Chlamydia trachomatis (Ct) infection in biopsy material
from the tubes. Pervious work, using different tests, re-
vealed evidence ofpersistent chlamydial infection in simi-
lar women with a history oftreatment.
Subjects: Ten infertile women, with orwithout a past
history of pelvic inflammatory disease, lower genital tract
chlamydial infection or episodes of pelvic pain, without
clinical signs ofupper or lower genital tract infection, found
on previous laparoscopy to have tubal disease, undergoing
laparoscopy to assess and repair the tubal damage.
Method: Immediately prior to laparoscopy, a routine
endocervical chlamydial swab and serological test for
antichlamydial antibodies were taken. Minimal tissue bi-
opsies were taken from the membrane and adhesions bilat-
erally and tested for Ct by modified PCR. (As these modifi-
cations are untested, we cannot use them as a basis for treat-
ment and so all patients will be offered postoperative
azithromycin, as wEll as their partners). Delay in obtaining
Ethical Committee approval, now secured, first patients to
be seen this week.
Comment: If the anticipated persistent cases of
chlamydial infection are found, preoperative effective
antichlamydial treatment will be indicated for all such cases
to prevent reactivation after surgery.
Problems of Diagnosis and Treatment of Genital
Chlamydia Infections In Latvia
G Lazdane, zP-A Mardh
IDepartment ofOb/Gyn, MedicalAcademy ofLatvia,
2Institute of Clinical Bacteriology, Uppsala University,
Sweden
Objective: To analyze the incidence and the cases of
misdiagnosis of genital chlamydia infections in Latvia as
well as the methods oftreatment used. The work was per-
formed as a part of the evaluation of the situation of the
reproductive health ofwomen and the medical care assess-
ment in Latvia.
Methods: We analyzed data from State Centre for
Sexually Transmitted Diseases of Latvia and Department
of Social Statistics of Ministry of Welfare of Latvia. We
compared the data mentioned in the latest medical publica-
tions in Latvia (1993-1996) dealing with the problems of
genital chlamydiosis with the results obtained from the col-
laboration study with the Institute of Clinical Bacteriology
ofUppsala University "The epidemiology of genital Infec-
tions in Europe". This study included PCR diagnostics of
urine samples of200 women attending the family planning
centre. The retrospective analysis of the case histories of
100 cases of female genital chlamydial infection attending
7 different out-patient clinics in Riga was performed using
a special questionnaire.
Results: Genital chlamydiosis is one of the report-
able sexually transmitted diseases in Latvia and its inci-
dence rate is growing (1992 832; 1995 -4520 cases). The
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existing medical care system where the costs of laboratory
tests are not covered by the sick fund influences the quality
of diagnosis and appropriate treatment. There is a great
difference in the incidence rate of Chlamydia positive pa-
tients reported by the laboratories performing the tests (up
to 60-70% Chlamydia positive clients) with the data ob-
tained during the collaborative study with the Uppsala
University (3.8% Chlamydia positive women). When
analysing the case histories of the treated patients there
were errors ofdiagnostic, management and treatment in 38%
of cases.
Conclusions:
1. Due to the use of unspecific methods of diagnosis of
genital chlamydial infections in Latvia, the statisti-
cal data characterizing this effect in Latvia are not
reliable.
2. The cases of false-positive results and unnecessary
treatment happen in more than one third of the re-
ported cases of genital chlamydiosis in Latvia.
3. The government of Latvia is to review the state bud-
get for health care and provide means to cover the
expenses ofspecific methods ofdiagnostic ofChlamy-
dia trachomatis infection.
4. Specialized training in detection and counseling on
genital chlamydial infections should be organized
for health care providers in Latvia that would include
assessment of obtained knowledge.
Detection of IgM and IgG Antichlamydial Antibodies in
Patients With Nongonococcal Urethritis Caused by
Chlarnydia trachornatis
S Vesle,M Nedeljkovic,S Djukie, T Mandic
1Institute ofDermatovenereology, Clinical Centre of
Serbia, Belgrade, Yugoslavia, 2Institute ofMicrobiology
and Immunology, University ofBelgrade, Yugoslavia
A total of 1052 patients with nongonococcal uretheiris
were included in this study. Detection of Chlamydia
trachomatis from urethral secretions was made by using
direct immunofluorescence test with FITC-labelled mono-
clonal antibodies (DIF). The indirect immunofluorescence
test (IFA) was performed in order to determine the titre of
IgM and IgG antichlamydial antibodies in patients’ sera.
Chlamydia trachomatis was detected in 545 (51.8%) out of
1052 patients with nongonococcal urethritis.
Antichlamydial IgM antibodies (titre > 8) were detected in
436 (80.0%), and IgG antibodies (titre > 16), were detected
in 473 (86.8%) out of 545 patients with Chlamydia
trachomatis-positive nongonococcal urethritis. A good
correlation between results obtained by the direct and indi-
rect immunofluorescence tests was found (Rxy=0.71).
Therefore, exact diagnosis ofchlamydial urethral infection
requires using both these methods (DIF and IFA). Priority
should be given to DIF test, because it proves the existence
of causative agent, while IFA test plays a complementary
role and can be helpful in following up ofthe dynamics of
chlamydial urethral infection.
InVitro Neutralization Of Chlamydia pneumoniae:
InfectivityWith Patient Sera and With Monoclonal
Antibodies
HM Freidank,MWiedmann-AI-Ahmad
Institutfur Medizinische Mikrobiologie, Freiburg,
Germany
IgG and IgA antibodies to Chlamydia pneumoniae
were determined with the micro-immunofluorescence (MIF)
test according to Wang and Grayston in more than 2000
serum samples. 33 sera containing both IgG and IgA anti-
bodies and 35 sera positive for IgG and negative for IgA
antibodies to C.pneumoniae at different titers were selected
for determination of their neutralizing activity following
the method standardized for in vitro neutralization of
Chlamydia trachomatis by Byrne et al. In addition, 21 sera
negative for C. pneumoniae antibodies in the MIF test were
examined as well as a monoclonal antibody against C.
pneumoniae (RR-402, Washington Research Foundation)
and a panel ofnew monoclonal antibodies produced against
a purified 54 kDa protein of C. pneumoniae. Since studies
on the in vitro neutralization of C. trachomatis showed that
the results may depend on the cell line, the performance of
different cell lines (HL, Baby hamsterkidney, Buffalo Green
Monkey kidney cells) was evaluated. 30 of the 35 patient
sera with IgG antibodies and 31 ofthe 33 patient sera with
both IgG and IgA antibodies showed neutralizing activity
defined as >50% reduction in the inclusion count as com-
pared to the untreated control. 20 of the 21 sera negative
for C. pneumoniae antibodies in the MIF test did not neu-
tralize infectivity, whereas both the monoclonal antibody
RR-402 against C. pneumoniae and the monoclonal anti-
bodies against the 54 kDa-protein of C. pneumoniae showed
neutralization at a titer of>1"10000 and> "80, respectively.
The neutralizing ability of the sera correlated better with
MIF IgG titers than with IgA titers.
’ihl’amyd’ia Infections in Andrologic Clinic: Laboratory
Diagnosis
Gorpinchenko, L Dobrovolska,N Boyko
Institute of Urology and Nephrology, Ukraine
Objective:To study the frequency of occurrence of
Chlamydia trachomatis genitourinary infections in patients
attending Andrologic clinic in Kiev Institute of Urology.
Methods: It were used method of light microscopy
stained by Romanovsky-Gimze and immunofluorescent
method with monoclonal antibody to detect Chlamydia
trachomatis in urethra endothelial cells as well as indirect
blood immunofluorescent method. 68 men were examined.
All patients was divided into three groups: G1 patients
suffered from urethritis (23 men), G2 patients with prostatitis
(22 men) and G3 men with urethroprostatitis- (23 men).
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Results: Has been detectedby three methods that geni-
tourinary infections among examined men was caused by
Chlamydia trachomatis in 39.7% ofcases (27 men). In G
Chlamydia trachomatis was defined in 34.8% (8 men), and
in G2 36.4% (8 men). Among the patients ofG3 Chlamy-
dia trachomatis was observed more often (43.5% 10 men).
Mean frequency of occurrence of Chlamydia trachomatis
for G3 was significantly higher than G and G2. Diagnos-
tic values of light microscopy by Romanovsky-Gimze and
immunofluorescent method with monoclonal antibody to
Chlamydia trachomatis in urethra endothelial cells were
30% and 70% accordingly in comparative with indirect
blood immunoflluorescent method. Chlamydia trachomatis
was observed not only as monoinfection but also as mixed
infection with other infection agents. The association with
one kind of microorganisms was met more often (42.7%)
than with two (36.7%) or especially three infection agents
(18.6%).
Conclusions: These data demonstrate that Chlamy-
dia trachomatis is detected as an infectious agent causing
urethroprostatitis. The results show that indirect blood im-
munofluorescen method was the most available for diag-
nostics ofChlamydia trachomatis genitourinary infections.
Circulating IgG Antibodies to the Chlamydia trachomatis,
Escherichia coli And Human 60kD Heat Shock Proteins In
Women
S.S. Witkin M.Askienazy-Elbhar J. Henry-Suchet J.
Tort-Grumbach K. Sarjdine
IDept ofObstetrics and Gynecology, Cornell University
Medical College, New York, NY,, Laboratoire de Biologic
Medicale Magenta, Paris, France and 3Family Planning
Center, Hospital Saint Louis, Paris, France
The relation between circulating IgG antibodies
to the C. trachomatis and E. coli 60 kD heat shock proteins
(hsp60) and immunity to the corresponding human 60kD
heat shock protein was examined. 103 serum samples from
male and female subjects seen at the Hospital Saint Louis
in Paris were tested. Purified recombinant E. coli hsp60
(GroEL) and human hsp60, both from StressGen (Victoria,
BC, Canada), as well as synthetic peptides corresponding
to unique (amino acids 151-162) and conserved (amino
acids 260-271) epitopes of the C. trachomatis hsp6o were
utilized to test for antibodies by ELISA. Antibodies to
chlamydial hsp60 epitopes 151-162 and 260-271 were de-
tected in 8 (7.8%) and 27 (26.2%) sera, respectively. Anti-
bodies to the E. coli and human hsp60 were each identified
in 11 (10.7%) samples. As expected the presence of anti-
bodies to the two synthetic peptides were highly correlated
(p-0.0002). Antibody to peptide 151-162 was detected in
26.9% of sera with, and in only 1.3% of sera without, anti-
body to peptide 260-271. Ofmajor interest was the obser-
vation of the unique association between antibodies to the
conserved chlamydial hsp60 peptide 260-271 and antibod-
ies to human hsp60 (p=0.03). Antibodies to human hsp60
were present in 22.2% ofwomen with, and in 6.6% ofwomen
without, antibodies to chlamydial hsp60 epitope 260-271.
In marked contrast, there was no association between anti-
bodies to chlamydial hsp60 epitope 151-162 or the E. coli
hsp60 and antibodies to human hsp60. Antibodies to pep-
tide 260-271 were more prevalent in women (35.1%) than
inmen (13.0%) (p=0.01). However, there was no difference
in the prevalence ofhuman hsp60 antibodies between men
(10.9%) and women (10.5%). The data reinforce previous
studies suggesting that immune sensitization to an epitope
ofthe C. trachomatis hsp60 that is homologous to an epitope
in the human hsp60 could lead to the induction of autoan-
tibodies to the human hsp60 in some individuals. The rela-
tion between hsp60 antibodies and antibodies to C.
trachomatis surface antigens and to clinical diagnosis is
currently being evaluated.
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